These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19333704)

  • 21. [Impact of prostaglandin-F(2alpha)-analogues and carbonic anhydrase inhibitors on central corneal thickness -- a cross-sectional study on 403 eyes].
    Viestenz A; Martus P; Schlötzer-Schrehardt U; Langenbucher A; Mardin CY
    Klin Monbl Augenheilkd; 2004 Sep; 221(9):753-6. PubMed ID: 15459842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deepening of lid sulcus from topical bimatoprost therapy.
    Peplinski LS; Albiani Smith K
    Optom Vis Sci; 2004 Aug; 81(8):574-7. PubMed ID: 15300114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased periocular pigmentation with ocular hypotensive lipid use in African Americans.
    Sodhi PK; Verma L; Ratan SK
    Am J Ophthalmol; 2004 Apr; 137(4):783. PubMed ID: 15059736
    [No Abstract]   [Full Text] [Related]  

  • 24. Periocular changes in topical bimatoprost and latanoprost use.
    Karslioğlu MZ; Hoşal MB; Tekeli O
    Turk J Med Sci; 2015; 45(4):925-30. PubMed ID: 26422869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of travoprost on intraocular pressure during 12 months of treatment for normal-tension glaucoma.
    Suh MH; Park KH; Kim DM
    Jpn J Ophthalmol; 2009 Jan; 53(1):18-23. PubMed ID: 19184304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood-aqueous barrier changes after the use of prostaglandin analogues in patients with pseudophakia and aphakia: a 6-month randomized trial.
    Arcieri ES; Santana A; Rocha FN; Guapo GL; Costa VP
    Arch Ophthalmol; 2005 Feb; 123(2):186-92. PubMed ID: 15710814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Audible clicking on blinking: an adverse effect of topical prostaglandin analogue medication.
    Abedi F; Chappell A; Craig JE
    Clin Exp Ophthalmol; 2017 Apr; 45(3):304-306. PubMed ID: 27868329
    [No Abstract]   [Full Text] [Related]  

  • 28. Latisse-induced periocular skin hyperpigmentation.
    Priluck JC; Fu S
    Arch Ophthalmol; 2010 Jun; 128(6):792-3. PubMed ID: 20547960
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of topical travoprost eye drops given once daily and timolol 0.5% given twice daily in patients with open-angle glaucoma or ocular hypertension.
    Goldberg I; Cunha-Vaz J; Jakobsen JE; Nordmann JP; Trost E; Sullivan EK;
    J Glaucoma; 2001 Oct; 10(5):414-22. PubMed ID: 11711841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abdominal cramp as an adverse effect of travoprost.
    Lee YC
    Am J Ophthalmol; 2005 Jan; 139(1):202-3. PubMed ID: 15652856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of tropical travoprost eye drops given once daily and timolol 0.5% given twice daily in patients with open-angle glaucoma or ocular hypertension. J. Glaucoma 2001;10:414-22.
    Goldberg I
    J Glaucoma; 2002 Jun; 11(3):275. PubMed ID: 12140407
    [No Abstract]   [Full Text] [Related]  

  • 32. [Periocular hyperpigmentation following travoprost application].
    Schmutz JL; Barbaud A; Tréchot P
    Ann Dermatol Venereol; 2008; 135(6-7):537. PubMed ID: 18598816
    [No Abstract]   [Full Text] [Related]  

  • 33. Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.
    Camras CB
    Am J Ophthalmol; 2002 May; 133(5):732; author reply 732-3. PubMed ID: 11992888
    [No Abstract]   [Full Text] [Related]  

  • 34. Eyelash growth induced by topical prostaglandin analogues, bimatoprost, tafluprost, travoprost, and latanoprost in rabbits.
    Giannico AT; Lima L; Russ HH; Montiani-Ferreira F
    J Ocul Pharmacol Ther; 2013 Nov; 29(9):817-20. PubMed ID: 23981234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of travoprost 0.0015% and 0.004% with timolol 0.5% in patients with elevated intraocular pressure: a 6-month, masked, multicenter trial.
    Fellman RL; Sullivan EK; Ratliff M; Silver LH; Whitson JT; Turner FD; Weiner AL; Davis AA;
    Ophthalmology; 2002 May; 109(5):998-1008. PubMed ID: 11986110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A three-month, multicenter, double-masked study of the safety and efficacy of travoprost 0.004%/timolol 0.5% ophthalmic solution compared to travoprost 0.004% ophthalmic solution and timolol 0.5% dosed concomitantly in subjects with open angle glaucoma or ocular hypertension.
    Hughes BA; Bacharach J; Craven ER; Kaback MB; Mallick S; Landry TA; Bergamini MV
    J Glaucoma; 2005 Oct; 14(5):392-9. PubMed ID: 16148589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comment on Efficacy and tolerability of prostaglandin analogs.
    Eisenberg D
    J Glaucoma; 2009 Aug; 18(6):498; author reply 498-9. PubMed ID: 19593206
    [No Abstract]   [Full Text] [Related]  

  • 38. Unilateral Prostaglandin-Associated Periorbitopathy: A Syndrome Involving Upper Eyelid Retraction Distinguishable From the Aging Sunken Eyelid.
    Rabinowitz MP; Katz LJ; Moster MR; Myers JS; Pro MJ; Spaeth GL; Sharma P; Stefanyszyn MA
    Ophthalmic Plast Reconstr Surg; 2015; 31(5):373-8. PubMed ID: 25393907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A 1-year study to compare the efficacy and safety of once-daily travoprost 0.004%/timolol 0.5% to once-daily latanoprost 0.005%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
    Topouzis F; Melamed S; Danesh-Meyer H; Wells AP; Kozobolis V; Wieland H; Andrew R; Wells D
    Eur J Ophthalmol; 2007; 17(2):183-90. PubMed ID: 17415690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eyelid hypertrichosis associated with latanoprost is reversible.
    O'Toole L; Cahill M; O'Brien C
    Eur J Ophthalmol; 2001; 11(4):377-9. PubMed ID: 11820311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.